Abiopharma

Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET

Hadron Energy Aligns Valuation for Business Combination to $600M, Signaling Long-Term Market Discipline After GigCapital7 Form S-4 Registration Statement Declared Effective

MaxsMaking Inc. Commences U.S. Business Operations

Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update

M2i Global, along with Volato Group, and Regenerate Technology Global Execute Strategic Partnership to Advance Battery Recycling Technologies to the U.S.

Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks

Abacus Global Management to Participate in the 2026 Milken Institute Global Conference

CenterWell Introduces the Fulfillment Index, a New Measure of What It Means to Age Well

MainStreet Bancshares, Inc. Announces First Quarter 2026 Results

VNET Announces Changes to Leadership Team